Why the study?
Does a more intensive blood pressure goal improve cardiovascular and renal outcomes in patients with diabetic nephropathy?
Does a more intensive blood pressure goal improve cardiovascular and renal outcomes in patients with diabetic nephropathy?
This review discusses the pros and cons of intensive versus less intensive blood pressure targets on cardiovascular and renal outcomes in patients with diabetic nephropathy.
Optimal BP targets in diabetic nephropathy remain undefined; leaves open need for dedicated RCTs to guide practice.
Diabetic nephropathy represents a condition frequently detected in current clinical practice characterized by a very high cardiovascular risk profile. Blood pressure reduction via antihypertension drug treatment represents a therapeutic approach capable of exerting favorable effects on renal and cardiovascular outcomes. The purpose of this article is to review the current literature and results of key clinical trials pertaining to blood pressure goals of antihypertension treatment in these patients. The pros and cons of a less or a more intensive blood pressure goal in diabetic nephropathy will be discussed, with particular emphasis on the cardiovascular and renal effects of each therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Grassı et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: